Our resource hub is home to a wealth of articles, stories and videos about managing and living with type 1 diabetes.
Place your order for our free information packs that support adults and children who have been recently diagnosed.
Our researchers are working on different ways to develop a cure for type 1 diabetes - from growing insulin-producing beta cells in labs to hacking the immune system.
Learn about the technologies that can deliver insulin automatically when needed. And discover the next generation of insulins that are currently being developed.
You could win a cash prize of up to £25,000 when you play the Breakthrough T1D lottery. As well as the chance to win great prizes, you’ll also help fund our research to find a cure for type 1 diabetes.
Your donations help support people living with type 1 diabetes today and fund the best treatment and cure research, no matter where in the world it takes place.
The announcement is the biggest treatment breakthrough for type 1 diabetes since the discovery of insulin.
Join our Virtual Triathlon Challenge and swim, cycle and run while raising money to fund Breakthrough T1D’s life-changing type 1 research.
We provide a wealth of information and free resources to help you support and empower your patients or students.
Take our free course for schools to learn more about supporting pupils with type 1 diabetes in educational settings.
JDRF has now rebranded to Breakthrough T1D. Our name has changed, our mission has not.
Home > About Breakthrough T1D UK & our impact > Our research > Research projects > Supplying researchers with pancreas samples from donors
The current funding is for Professor Paul Johnson and his team to continue to run the Human Islet Isolation Facility at the University of Oxford. Their goal is to supply 1 million pancreatic islets to research each year.
The lab receives human bodies that have been donated to science and take out the pancreas. They then dissect the pancreas, taking slices of the whole pancreas as well as isolating islets within it. These isolations are performed within a state-of-the-art isolation facility.
Once the scientists have prepared the samples, they use a computer-based algorithm to distribute them across Europe. The system matches the characteristics of the samples available with the requirements of each research lab. This ensures fair allocation of islets and maximum efficiency by only offering researchers islets that are suitable for their experiments.
Pancreatic islets are clusters of cells in the pancreas. They contain cells that make hormones, including the insulin-producing beta cells. All mammals have pancreatic islets, which are also called the Islets of Langerhans.
Human islets are a vital resource for researchers investigating the causes of type 1 and those trying to develop new treatments and cures. Previously, a lot of research on islets has been carried out using animal cells. But we need to understand more about the biology of the human pancreas to find ways of treating and curing type 1. Our pancreases are tucked deep inside our bodies, so studying it in living people is very difficult. Studying human pancreas samples from organ donors can help fill the gaps in our knowledge and lay the foundations for future treatments and cures.
Thanks to new initiatives to increase the quality and quantity of organ donations, the Human Islet Isolation Facility can now receive pancreases from donors with diabetes. This funding from Breakthrough T1D UK will allow Professor Johnson’s team to supply their network of research labs with pancreas samples from donors both with and without diabetes. Including donors with diabetes will help researchers to investigate the causes of type 1, which remain largely unknown.
The centre provides islets and pancreas samples to many projects investigating type 1. These studies range from exploring the underlying biology of the immune attack on the beta cells to growing beta cells in the lab. Continuing to supply researchers with pancreas and islet samples allows more research that improves our understanding of type 1 and brings us closer to treatments and cures for the condition. Unravelling the causes of type 1 is crucial to preventing it and achieving our vision of a world without type 1.
We fund lots of research projects that use pancreas and islet samples. Through the Type 1 Diabetes Grand Challenge, we are funding Professor Sarah Richardson to study the immune system attack behind type 1. Sarah is studying pancreas samples from people with type 1 to find differences in how their immune system attacks and destroys beta cells.
Dr Matthew Anson is studying whether hybrid closed loop technology, also known as an artificial pancreas, affects the worsening of diabetic eye disease.
Dr Samet Sahin is developing a simple tool to allow healthcare professionals to quickly and easily check someone’s C-peptide levels, a measure of how much insulin they are releasing.
Dr Thomas George Hill is studying a type of pancreatic islet cell, called a delta cell, which he thinks could be targeted with a treatment to help prevent low blood glucose in type 1 diabetes.
Dr Rebecca Dewhurst-Trigg is investigating how supportive cells called mesenchymal stromal cells may help protect insulin-making beta cells from being destroyed in type 1 diabetes.